5 Personalized Medicine Stocks Billionaires Are Loading Up On

2. Johnson & Johnson (NYSE:JNJ)

Number of Billionaire Investors: 17

Dollar Value of Billionaire Holdings: $2,834,974,813

Number of Hedge Fund Holders: 86

Johnson & Johnson (NYSE:JNJ) is working actively to invest in the research and development of personalized treatments. The company, in collaboration with Janssen Research & Development LLC, initiated the Immunology Innovations QuickFire Challenge to encourage advancements in precision medicine.

As of Q1 2023, 86 hedge funds held a stake in Johnson & Johnson (NYSE:JNJ). D E Shaw raised its stake in Johnson & Johnson (NYSE:JNJ) by 86% during the first quarter of the year.